Director/PDMR Shareholding

Dechra Pharmaceuticals PLC
20 December 2007


                           Dechra Pharmaceuticals PLC

                                 (the Company)

                         Directors / PDMR Sharedealing


20 December 2007


Dechra Pharmaceuticals PLC announces that, on 19 December 2007, the following
Directors and PDMR's exercised options over ordinary shares of 1p each in the
Company, granted to them on 16 November 2004 pursuant to the Dechra
Pharmaceuticals Plc Long Term Incentive Plan (the LTIP), at an exercise price of
£1 each:

Name    Capacity  Options    Shares    Sale     Total beneficial shareholding
                  Exercised  Sold      Price    following this announcement
                                       per
                                       share

Ian     Director   48,589    48,589    £3.50                           662,819
Page

Simon   Director   33,096         0        0                           789,868
Evans

Edwin   Director   31,348    31,348    £3.50                           393,990
Torr

Giles   PDMR       17,768     7,308    £3.50                            44,898
Coley

Mike    PDMR       28,213    11,603    £3.50                           642,382
Annice

Peter   PDMR       23,511     9,670    £3.50                            43,280
Graham


The exercise of the LTIP options were subject to the achievement of performance
conditions which were satisfied in full.


All Directors (other than Simon Evans) and PDMR's have sold 41% of the
shareholding acquired pursuant to the LTIP exercise in order to fund the
resulting tax liability. Ian Page and Ed Torr have both sold the remaining 59%
of the shareholding acquired with the intention of taking up additional
entitlements in respect of the Company's Placing and Open Offer (announced on 12
December 2007) over and above their proposed investments stated in the
Prospectus.


As a result of this additional investment Ian Page will now seek to invest a
total of £164,825 in the open offer and Ed Torr a total of £99,402.





Enquiries:

Zoe Bamford

Company Secretary


01782 771100



                      This information is provided by RNS
            The company news service from the London Stock Exchange